CD146, a novel target of CD44-signaling, suppresses breast tumor cell invasion

[1]  M. Abdraboh,et al.  TGF-β2: A Novel Target of CD44-Promoted Breast Cancer Invasion , 2013, Journal of Cancer.

[2]  M. Aurrand-Lions,et al.  CD146 Expression in Human Breast Cancer Cell Lines Induces Phenotypic and Functional Changes Observed in Epithelial to Mesenchymal Transition , 2012, PloS one.

[3]  C. Gondi,et al.  MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells. , 2012, Cellular signalling.

[4]  M. Abdraboh,et al.  Survivin is a novel target of CD44-promoted breast tumor invasion. , 2011, The American journal of pathology.

[5]  Hua Jiang,et al.  The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7 , 2011, BMC Cancer.

[6]  Mieke Schutte,et al.  Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146 , 2011, Breast Cancer Research and Treatment.

[7]  Rie Kondo,et al.  Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis , 2011, BMC Cancer.

[8]  F. Dignat-George,et al.  CD146 soluble : une nouvelle molécule angiogénique impliquée en physiopathologie☆ , 2010 .

[9]  F. Vély,et al.  CD146 Short Isoform Increases the Proangiogenic Potential of Endothelial Progenitor Cells In Vitro and In Vivo , 2010, Circulation research.

[10]  F. Bagnoli,et al.  The interaction between aromatase, metalloproteinase 2,9 and CD44 in breast cancer. , 2010, Revista da Associacao Medica Brasileira.

[11]  L. Ouafik,et al.  Soluble CD146 displays angiogenic properties and promotes neovascularization in experimental hind-limb ischemia. , 2010, Blood.

[12]  G. Lip,et al.  Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index. , 2009, Neoplasia.

[13]  A. Fernando,et al.  Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146. , 2009, Biochimica et biophysica acta.

[14]  K. Eidne,et al.  hShroom1 links a membrane bound protein to the actin cytoskeleton , 2009, Cellular and Molecular Life Sciences.

[15]  F. Bertucci,et al.  CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines , 2009, Breast Cancer Research.

[16]  M. Abdraboh,et al.  In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver. , 2007, The American journal of pathology.

[17]  Dominique Dunon,et al.  Dual Role of Melanoma Cell Adhesion Molecule (MCAM)/CD146 in Lymphocyte Endothelium Interaction: MCAM/CD146 Promotes Rolling via Microvilli Induction in Lymphocyte and Is an Endothelial Adhesion Receptor1 , 2007, The Journal of Immunology.

[18]  Hwai-Shi Wang,et al.  CD44 crosslinking-mediated matrix metalloproteinase-9 relocation in breast tumor cells leads to enhanced metastasis. , 2007, International journal of oncology.

[19]  Pengcheng Bu,et al.  A novel antibody AA98 V(H)/L directed against CD146 efficiently inhibits angiogenesis. , 2007, Anticancer research.

[20]  P. Bonnier,et al.  Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype. , 2007, Human pathology.

[21]  Pengcheng Bu,et al.  Visualization of CD146 dimerization and its regulation in living cells. , 2007, Biochimica et biophysica acta.

[22]  A. Ouhtit,et al.  Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells , 2006, Oncogene.

[23]  F Dignat-George,et al.  Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry , 2006, Cytometry. Part B, Clinical cytometry.

[24]  N. Greenberg,et al.  Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model. , 2005, The Journal of urology.

[25]  Jer-Tsong Hsieh,et al.  The role of cell adhesion molecule in cancer progression and its application in cancer therapy. , 2004, Acta biochimica Polonica.

[26]  M. Zöller,et al.  CD44 in Cancer Progression: Adhesion, Migration and Growth Regulation , 2003, Journal of Molecular Histology.

[27]  A. Bretscher,et al.  ERM proteins and merlin: integrators at the cell cortex , 2002, Nature Reviews Molecular Cell Biology.

[28]  A. Le Bivic,et al.  Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. , 2001, Blood.

[29]  M. Amin,et al.  Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression. , 2001, Gene.

[30]  M. Amin,et al.  Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues , 2001, The Prostate.

[31]  M. Herlyn,et al.  Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication , 2001, Oncogene.

[32]  I. Shih,et al.  A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[33]  J. Palazzo,et al.  The cell-cell adhesion receptor Mel-CAM acts as a tumor suppressor in breast carcinoma. , 1997, The American journal of pathology.

[34]  J. Johnson,et al.  Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. , 1997, Cancer research.

[35]  D. Elder,et al.  Isolation and functional characterization of the A32 melanoma-associated antigen. , 1994, Cancer research.

[36]  J. Johnson,et al.  The progression associated antigen MUC18: a unique member of the immunoglobulin supergene family , 1993, Melanoma research.

[37]  J. Lehmann,et al.  MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[38]  B. Bauvois,et al.  New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. , 2012, Biochimica et biophysica acta.

[39]  Judith P. Johnson.  Cell Adhesion Molecules in the Development and Progression of Malignant Melanoma , 2004, Cancer and Metastasis Reviews.

[40]  M. Herlyn,et al.  Dynamics of cell interactions and communications during melanoma development. , 2002, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[41]  J. Johnson,et al.  MUC18: A cell adhesion molecule with a potential role in tumor growth and tumor cell dissemination. , 1996, Current topics in microbiology and immunology.

[42]  C. Bucana,et al.  Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. , 1993, Melanoma research.